A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

Abstract

We found a positive effect of recombinant human nerve growth factor on neuropathic pain and pin sensitivity in HIV-associated sensory neuropathy. rhNGF was safe and well tolerated, but injection site pain was frequent.